Healio

Pharmacotherapy sets new standard of care for retinal vein occlusion, but questions remain

Please provide your email address to receive an email when new articles are posted on . For the last 2 decades, there has been little debate about the preferred treatment of retinal vein occlusion.
Healio

FDA designates recall of intra-aortic occlusion device as class 1

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA has designated Edwards Lifesciences’ product ...